Announcements Trials
Browse Landscape

Phase

Phase 2 38Phase NA 28Phase 3 16Phase EARLY_PHASE1 7Phase 4 7Phase 2/3 5Phase 1 5Phase 1/2 4

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3CNS 1

Conditions

Breast Neoplasms 2Glioblastoma 1Carcinoma, Intraductal, Noninfiltrating 1Biomarker Change Linked to Breast Cancer 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Cholecalciferol × Clear all
NCT02856503 2026-04-17

Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors

University of Miami

Phase 1/2 Withdrawn
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01425476 2017-08-09

Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors

Hartford Hospital

Phase 1/2 Completed
45 enrolled
Breast

Breast Neoplasms

NCT01769625 2017-08-09

Changes in Biomarkers Using Prostaglandin Inhibitors

Hartford Hospital

Phase 1/2 Completed
31 enrolled
Breast

Biomarker Change Linked to Breast Cancer

NCT01181193 2011-03-29

Vitamin D for Treatment of Glioblastoma Multiforme

Soroka University Medical Center

Phase 1/2 Unknown
20 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡